Latest Shareholder Approval News

Golden Horse Minerals ramps up exploration at its Southern Cross gold project with strong high-grade results and moves to acquire the Sorrel Copper Project for $3 million, backed by a $15 million capital raise.

MAC Copper Limited shareholders will vote on a court-sanctioned scheme of arrangement proposing Harmony Gold’s acquisition at a 32% premium. The transaction, valued at over $1 billion, requires shareholder and regulatory approvals before completion.

Horizon Minerals reported steady gold output from Boorara and Phillips Find projects, generating nearly A$39 million in revenue for the June quarter, while progressing a major plant conversion study and securing $30 million in new funding.

Hastings Technology Metals has secured shareholder approval for a joint venture with Wyloo, granting Wyloo a 60% stake and operational control of the Yangibana Rare Earths Project, setting the stage for accelerated development and production.

Manhattan Corporation reports progress on its planned acquisition of the Hook Lake Project in Nunavut alongside promising high-grade gold drilling results at Tibooburra and ongoing lithium exploration in Nova Scotia.

Mont Royal Resources is progressing its merger with Commerce Resources to create a dual-listed Canadian critical metals developer, combining rare earth and lithium assets in Quebec.

Alchemy Resources has made significant strides in its June quarter exploration, identifying major lithium targets at Karonie and acquiring full iron ore rights at Bryah, while advancing base metals exploration in NSW.

Astron Corporation Limited’s securityholders have overwhelmingly approved a scheme to shift the company’s domicile from Hong Kong to Australia, setting the stage for a significant corporate restructuring.

Renegade Exploration has acquired four promising projects in Nevada's Walker Lane trend, revealing impressive high-grade gold and silver samples, while advancing its Yukon and Australian assets amid a recent $1.8 million capital raise.

Opyl Limited has secured three key partnerships validating its AI-driven TrialKey platform, completed a strategic review to boost AI capabilities, and strengthened its balance sheet with a $1.5 million capital raise and Bitcoin investment.

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Octava Minerals has successfully completed the initial phase of its $1.5 million capital raise, positioning the company to advance exploration and due diligence at its promising Federation Copper-Zinc-Silver Project.